Risk of cervical pre-cancer and cancer in women with multiple sclerosis exposed to high efficacy disease modifying therapies.

Bridge, Francesca; Brotherton, Julia M L; Foong, Yi; Butzkueven, Helmut; Jokubaitis, Vilija G; Van der Walt, Anneke

Bridge, Francesca; Brotherton, Julia M L; Foong, Yi; Butzkueven, Helmut; Jokubaitis, Vilija G; Van der Walt, Anneke.

Afiliação

Bridge F; Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia.
Brotherton JML; Department of Neurology, Alfred Health, Melbourne, VIC, Australia.
Foong Y; Australian Centre for the Prevention of Cervical Cancer (Formerly Victorian Cytology Service), Carlton South, VIC, Australia.
Butzkueven H; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.
Jokubaitis VG; Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia.
Van der Walt A; Department of Neurology, Alfred Health, Melbourne, VIC, Australia.

Front Neurol ; 14: 1119660, 2023.

Article em En | MEDLINE | ID: mdl-36846149

Palavras-chave

autoimmune disease (AID); cervical cancer; disease modifying therapy (DMT); human papilloma virus (HPV); multiple sclerosis (MS)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Front Neurol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google